Precision Health and PGx Podcast

Pharmacy Podcast Network
  • 4.7 (12)
  • BUSINESS
  • UPDATED SEMIMONTHLY
Precision Health and PGx Podcast

This podcast is primarily intended for Pharmacists and Physicians. If you’re interested in learning more about what role Pharmacogenomics plays within the genome and drug response subscribe to this podcast. We will be talking about how Pharmacogenomics analyzes the genetic makeup of a patient affects their response to drugs.

  1. 12/10/2024

    Pharmacists Value in the Clinical Pharmacogenomics Lab with Dr. Jeremy Stuart, Chief Scientific Officer, Precision Genetics | Precision Health and PGx Podcast

    Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Dr. Jeremy Stuart, Chief Scientific Officer and laboratory director for Precision Genetics, discuss pharmacists value as employees in clinical pharmacogenomics testing laboratories. Having employed pharmacists in his laboratories, Dr. Stuart will provide his first-hand examples to illustrate how pharmacists have benefited his laboratories. Dr. Winslow and Dr. Sarrami will also share their real-world experiences working for clinical pharmacogenomics laboratories to help the laboratory achieve its goals.This episode is a must listen for laboratories who are vested in their pharmacogenomics testing's financial success. After listening to this episode, the learner will be able to describe responsibilities and roles in pharmacogenomics pharmacists fulfill in clinical labs, name specific real-world examples that illustrate pharmacists’ contributions to pharmacogenomics in the clinical laboratory, and name education, training, and work experiences that prepare pharmacists to assume advanced practice roles in clinical laboratories. Dr. Jeremy Stuart has extensive experience in the life science industry. He specializes in commercial operations, technology development and transfer, manufacturing design, and validation of laboratory developed tests (LDTs). He currently serves as the Chief Scientific Officer for Precision Genetics and serves as their Laboratory Director.  Dr. Stuart was part of the senior management team that completed a management buyout of Lab21 Inc. to form Selah Genomics and the subsequent sale of Selah to EKF. Dr. Stuart led the development and validation of all of Selah’s molecular assays and oversaw their clinical studies. Dr. Stuart was also a member of the Agencourt Personal Genomics team, where he co-developed the SOLiD next-generation sequencing technology that was subsequently acquired by Applied Biosystems.   Before entering industry, Dr. Stuart completed his postdoctoral work at the the Harvard School of Public Health, earned his master’s degree in Toxicology from the University of Minnesota, and his doctorate in Genetics & Complex Diseases from Harvard University. As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University’s Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University. Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association’s (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" p

    48 min

  2. 11/25/2024

    Demystifying Medicaid Coverage and Reimbursement for Pharmacogenomics Testing | Precision Health and PGx Podcast

    In this episode, Dr. Mary Weissman, Dr. Lexi Wensel, and Dr. Becky Winslow discuss Medicaid’s coverage of pharmacogenomics testing and Medicaid’s reimbursement of a pharmacist’s time spent provisioning PGx testing and providing PGx inclusive medication therapy management for Medicaid beneficiaries. We teach the listener how to locate, navigate, and understand Medicaid-managed care organizations’ coverage and reimbursement policies for pharmacogenomics testing and the billing codes pharmacists can use to bill for their time in providing PGx testing. Lastly, we analyze pharmacists' time investment versus Medicaid reimbursement of the pharmacists' time to project the financial return on investment of this business model for pharmacists.     After listening to this episode, the listener will understand what Medicaid and Managed Care Organizations (MCOs) are and their role in pharmacogenomics utilization; understand how to navigate managed care organizations' policies to determine coverage for pharmacogenomic testing and eligibility criteria; recognize the current Medicaid coverage landscape for pharmacogenomic testing, including eligibility criteria, coverage limitations, and variations across different states; and understand pharmacists' roles in the provision of pharmacogenomics testing and Medicaid’s reimbursement of a pharmacists’ time.

    31 min

  3. 05/30/2024

    The Couch, The Clinic, and the Scanner, an interview with Dr. Hellerstein | Precision Health and PGx

    David Hellerstein, MD, is professor of clinical psychiatry and an award-winning writer of nonfiction and fiction. Books such as Heal Your Brain: How the New Neuropsychiatry Can Help You Go from Better to Well (2011); A Family of Doctors (1994), a memoir of 5 generations of doctors in his family; Battles of Life and Death, an essay collection; and two novels, Loving Touches and Stone Babies. And recently The Couch, the Clinic, and the Scanner. A must read!A top psychiatric researcher, he has done cutting-edge studies on new treatment for depression, using MRI imaging to discover brain circuits related to illness and the effects of treatment. For the past five years, his research has focused on new psychedelic treatments of depression and other disorders, using psilocybin and other long-banned drugs.

    49 min

  4. 04/25/2024

    Pharmacogenomics Databases: What’s Available and How to Navigate Them | Precision Health and PGX

    Episode Summary:In recognition of National DNA Day, April 25, 2024, Dr. Mary Weissman, Miss Courtney Harmon, and Dr. Becky Winslow discuss clinical pharmacogenomics resources, what pharmacogenomics information they provide, and how to navigate and utilize the pharmacogenomics information to answer a prescriber’s clinical question about pharmacogenomics' relationship to an adverse drug event.  Listeners interested in learning a step-wise approach to using the Food and Drug Administration's (FDA's) Table of Pharmacogenetics Associations and the FDA Table of Pharmacogenomic Biomarkers in Drug Labeling, the Clinical Pharmacogenetics Implementation Consortium's (CPIC's) database, and the Pharmacogenomics Knowledgebase (PharmGKB) to demystify pharmacogenomics' role in adverse drug events will not want to miss this Precision Health and PGx Podcast episode. Biographies:Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over ten years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry to reduce barriers holding pharmacogenomics back from becoming a standard of care including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Acutis Diagnostics, Kentucky Teachers’ Retirement System, and GenXys. A sought-after pharmacogenomics subject matter expert, Dr. Winslow, is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.  Dr. Mary Weissman is a pharmacogenomics science, clinical utility and reimbursement expert and inGENEious RX Incorporated team member.  After earning her PharmD from the Arnold and Marie Schwartz College of Pharmacy, Dr. Weissman completed a two-year pharmacogenomics fellowship with a clinical diagnostic lab. Upon completing her academic training in pharmacology and pharmacogenomics, Dr. Weissman embarked on a journey to apply her expertise in clinical diagnostic laboratories and has held several key scientific and clinical roles in pharmacogenomics laboratories. Through informative presentations, training sessions, papers, and webinars, she has helped clarify pharmacogenomics' complexities and highlight its potential to revolutionize medication management strategies for pharmacogenomics' stakeholders.Miss Courtney Harmon is graduating from Manchester University's Pharmacy and Pharmacogenomics programs in 2024.  She serves as a P4 liaison for Manchester University's chapter of Industry Pharmacists Organization (IPhO) and she is interested in pursuing a career in industry pharmacy. She has worked for Walgreens pharmacy for the last eight years. References:1. Table of pharmacogenomic biomarkers in drug labeling. U.S. Food and Drug Administration. Published August 10, 2023. Accessed February 1, 2024. https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling 2. Table of pharmacogenetic associations. U.S. Food and Drug Administration. Published October 26, 2022. Accessed February 1, 2024. https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations 3. CPIC. Cpicpgx.org. Accessed February 1, 2024. https://cpicpgx.org 4. PharmGKB. PharmGKB. Accessed February 1, 2024. https://www.pharmgkb.orgKeywords: #pharmacogenomics #ingeneiousrx #PGx #pharmacists #precisionhealthandpgxpodcast #pharmacypodcastnetwork #pharmacogenetics #genetics #sources #resources #FDA #CPIC #PharmGKB

    25 min
  5. Genetic Insight: Exploring MTHFR and Mental Health | Precision Health and PGx

    03/19/2024

    Genetic Insight: Exploring MTHFR and Mental Health | Precision Health and PGx

    Towny Robinson is the CEO of JayMac Pharmaceuticals and the inventor of EnLyte and EnBrace HR. He is a national expert on Methylation Biochemistry/Genetics and Psychiatric Disorders. Visit his website to learn more: www.enlyterx.com/about-enlytewww.enlyterx.com/about-enlyteBehnaz Disclaimer: These are my personal views and opinions, and I am not speaking on behalf of Castle Biosciences, Inc.

    33 min

  6. 12/18/2023

    Medical Science Liaison, A Career Path for Pharmacists with Dr. Samuel Dyer | PGX For Pharmacists

    Special Episode: Travel with us in this journey through the fascinating world of Medical Science Liaison (MSL), new career path for pharmacists! Get firsthand knowledge from the CEO of The MSL Society and how to break into the amazing career path.We are giving away a signed copy of the book "The Medical Science Liaison Career Guide: How to Break Into Your First Role". To the one lucky aspiring MSL, please share our podcast link, tag Becky, Behnaz, and Samuel Dyer and make sure to use the hashtag PGx4Rx to be entered into the contest. The winners will be announced in the first week of January 2024. Behnaz Disclaimer: These are my personal views and opinions, and I am not speaking on behalf of Castle Biosciences, Inc.

    37 min

  7. 11/20/2023

    From PharmD to Pharmacogenomics Test Developer: Dr. Thierry Dervieux’s Story of Revolutionizing Healthcare Through Precision Medicine for Immune Modulated Inflammatory Diseases | PGx For Pharmacists

    Becky Winslow, BS, PharmD Host and Pharmacogenomics Medical Science Liaison; Behnaz Sarrami, MS, PharmD, Host and Pharmacogenomics Medical Science Liaison; Thierry Dervieux, PharmD, PhD, Chief Scientific Officer at Prometheus LaboratoriesDisclaimer:Behnaz Disclaimer: These are my personal views and opinions, and I am not speaking on behalf of Castle Biosciences, Inc. Becky Disclaimer: These are my personal views and opinions, and I am not speaking on behalf of any other entity.   Transcription:  100:00:06,190 --> 00:00:19,620You're listening to the Pharmacy podcast Network in a world where one size fits all medications dominate the pharmaceutical industry. 200:00:20,079 --> 00:00:24,750Precision medicine brings a ray of hope for those seeking customized health care. 300:00:25,350 --> 00:00:32,830Pharmacists have a unique opportunity to help people in need of specialized testing to ensure medications work as intended. 400:00:33,540 --> 00:00:44,680Welcome to PGX for pharmacists where we unravel the wonders of precision medicine and its potential to revolutionize the way we approach pharmacy care. 500:00:45,169 --> 00:00:52,790Get ready to uncover the secrets behind pharmacogenomics and how it's transforming lives one genome at a time. 600:00:52,799 --> 00:00:53,189Hello, 700:00:53,200 --> 00:00:53,950everyone. 800:00:54,159 --> 00:00:55,080I'm your host, 900:00:55,090 --> 00:00:56,389Doctor Becky Winslow. 1000:00:56,409 --> 00:01:09,860And you're listening to the PGX for Pharmacist podcast that we magazine recognized in 2021 as the ninth most listened to genetics podcasts in the world on the PGX for Pharmacist podcast. 1100:01:09,870 --> 00:01:16,690We explore all things pharmacogenomics related and our mission is to educate and advocate for PGX. 1200:01:16,769 --> 00:01:23,849We accomplish this mission through exclusive interviews with highly qualified and well experienced pharmacogenomics. 1300:01:23,860 --> 00:01:29,720Industry leaders such as today's special guest and my name is Baas Sami, 1400:01:29,730 --> 00:01:32,739the co-host of PGX for Pharms podcast, 1500:01:32,750 --> 00:01:33,860Pharmacogenomics, 1600:01:33,870 --> 00:01:36,819medical science liaison and a mentor to pharmacist. 1700:01:36,889 --> 00:01:40,239Connect with us on linkedin and let's get a conversation going. 1800:01:40,269 --> 00:01:46,720We want to hear from you and how you're impacting pharmacogenomic stakeholders and what you have learned throughout your journey. 1900:01:48,510 --> 00:01:49,010Ok. 2000:01:49,019 --> 00:01:50,819So without any further ado, 2100:01:50,839 --> 00:01:54,769I'm extremely pleased to introduce to our audience. 2200:01:54,919 --> 00:01:56,059Doctor Theory Devo, 2300:01:57,239 --> 00:02:01,129the Chief Scientific Officer at Prometheus Laboratories, 2400:02:01,139 --> 00:02:08,139and Perme Prometheus Laboratories is a reference clinical laboratory that's focused on the diagnosis, 2500:02:08,149 --> 00:02:13,330prognosis and monitoring of immune mediated inflammatory diseases. 2600:02:13,970 --> 00:02:14,229So, 2700:02:14,240 --> 00:02:14,649thank you, 2800:02:14,660 --> 00:02:17,759Doctor De for joining us on the podcast. 2900:02:17,770 --> 00:02:18,589Today. 3000:02:18,600 --> 00:02:23,190I'm excited to share your and Prometheus's story with our audience. 3100:02:23,649 --> 00:02:25,630Um in particular, 3200:02:25,639 --> 00:02:45,369I'm excited about you sharing your career journey as a farm D phd and Chief scientific officer and designer of the Predictor PK AD A which is a precision guided dosing test for the optimization of Humira Remicade and their bio cylinders. 3300:02:46,119 --> 00:02:46,449So, 3400:02:46,460 --> 00:03:04,220one of Bana's and my main goals for this episode of the PGX for Pharmacist podcast is to expand our audience's notion of what a PGX test looks like and to inspire them to think bigger

    29 min

  8. 09/18/2023

    Using Technology to Decrease Barriers to the Clinical Implementation of Pharmacogenomics: LetsGetChecked’s PGx Story | PGx For Pharmacists

    On this episode, Dr. Avni Santani, Chief Genomics Officer of Let's Get Checked, Dr. Behnaz Sarrami, and I discuss how Let's Get Checked solves several major barriers that have held pharmacogenomics back from becoming the standard of care in medication therapy management, pharmacists' critical and unique role in PGX at Let's Get Checked, and how nontraditional PGx payers are championing for PGx testing to decrease adverse drug events, increase therapeutic medication outcomes, and improve patient adherence to their medications.  https://www.letsgetchecked.com/mypgx/Becky Winslow, BS, PharmD and Behnaz Sarrami, MS, PharmD (Hosts) Avni A. Santani, PhD, FACMG, Chief Genomics Officer at LetsGetChecked New boost

    47 min
See All (64)

4.7
out of 5
12 Ratings

About

This podcast is primarily intended for Pharmacists and Physicians. If you’re interested in learning more about what role Pharmacogenomics plays within the genome and drug response subscribe to this podcast. We will be talking about how Pharmacogenomics analyzes the genetic makeup of a patient affects their response to drugs.

Information

  • Creator
    Pharmacy Podcast Network
  • Years Active
    2020 - 2024
  • Episodes
    64
  • Rating
    Clean
  • Copyright
    © 2023 Pharmacy Podcast Network
  • Show Website
    Precision Health and PGx Podcast

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada